Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation.

Background: N-acetyltransferase 2 (NAT2) enzyme is a Phase II drug-metabolizing enzyme that metabolizes different compounds. Genetic variations in can influence the enzyme's activity and potentially lead to the development of certain diseases.

Aim: This study aimed to investigate the association of variants with the risk of Type II diabetes mellitus (T2DM) and the lipid profile among Jordanian patients.